| Feb 10, 2025 |
Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, ne... |
Lack of Assurance of Sterility: There is a potential for leakage at the IV bo... |
Class II |
| Feb 22, 2023 |
Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL), 10 mL Single-Dose... |
Lack of Assurance of Sterility |
Class II |
| Feb 22, 2023 |
Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 8 mg/250 mL... |
Lack of Assurance of Sterility |
Class II |
| Feb 22, 2023 |
Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 4 mg/250 mL... |
Lack of Assurance of Sterility |
Class II |
| Feb 22, 2023 |
Phenylephrine HCl Injection, USP, 0.4 mg/10 mL (40 mcg/mL), 10 mL Single-Dose... |
Lack of Assurance of Sterility |
Class II |
| Feb 22, 2023 |
Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125... |
Lack of Assurance of Sterility |
Class II |
| Feb 22, 2023 |
Phenylephrine HCl in 0.9% Sodium Chloride Injection, USP, 50 mg/250 mL (200 m... |
Lack of Assurance of Sterility |
Class II |
| Feb 22, 2023 |
Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Single-Dose ... |
Lack of Assurance of Sterility |
Class II |
| Feb 22, 2023 |
Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 16 mg/250 m... |
Lack of Assurance of Sterility |
Class II |
| Jan 6, 2023 |
Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syri... |
Lack of Assurance of Sterility |
Class II |
| Nov 10, 2022 |
PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 5... |
CGMP Deviations: Potential for cross contamination due to product carry over. |
Class II |
| Nov 10, 2022 |
PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only... |
CGMP Deviations: Potential for cross contamination due to product carry over. |
Class II |
| Aug 10, 2022 |
Trisodium Citrate 0.5% Solution, (0.5%/4L), contains Per Liter: Sodium 140 mm... |
CGMP Deviations: Potential for cross-contamination due to product carryover d... |
Class II |
| Aug 10, 2022 |
PF-0.125% Bupivacaine HCl Injection, USP, 625 mg/500 mL (1.25 mg/mL), 500 mL ... |
CGMP Deviations: Potential for cross-contamination due to product carryover d... |
Class II |
| Aug 10, 2022 |
PF-Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL), One 4 mL Unit-Dose Via... |
CGMP Deviations: Potential for cross-contamination due to product carryover d... |
Class II |
| Aug 10, 2022 |
PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Un... |
CGMP Deviations: Potential for cross-contamination due to product carryover d... |
Class II |
| Jun 30, 2022 |
Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL) syringe, packag... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Anticoagulant Sodium Citrate Solution, USP 4%, 200 mg/5 mL (40 mg/mL) syringe... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate), 45 mg/5 mL... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Lidocaine HCl Injection, USP 1%, 50 mg/5 mL (10 mg/mL) syringe, packaged in 5... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Ketamine HCl Injection, USP, 50 mg/1 mL (50 mg/mL*) syringe, packaged in 5 x ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
EPINEPHrine Injection, USP, 1 mg/10 mL (100 mcg/mL) syringe, packaged in 5 x ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Oxytocin 30 Units/500 mL (0.06 Units/mL) in 0.9% Sodium Chloride Injection, U... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Lidocaine HCl Injection, USP 2%, 100 mg/5 mL (20 mg/mL) syringe, packaged in ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
EPINEPHrine Injection, USP, 0.1 mg/10 mL (10 mcg/mL) syringes, 5 x 10 mL Pre-... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
del Nido Cardioplegia Solution 1000 mL (1000 mL) Single-Dose Container IV bag... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
HYDROmorphone HCl Injection, USP, 10 mg/50 mL (0.2 mg/mL) syringes, 5 x 50 mL... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL)syringe, packaged i... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
0.125% Bupivacaine HCl Injection, USP, 62.5 mg/50 mL (1.25 mg/mL) syringes, p... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
HYDROmorphone HCl Injection, USP, 50 mg/50 mL (1 mg/mL) syringes, packaged in... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Glycopyrrolate Injection, USP, 1 mg/5 mL (0.2 mg/mL) syringes, packaged in 5 ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Morphine Sulfate Injection, USP, 50 mg/50 mL (1 mg/mL) syringe, packaged in 5... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Atropine Sulfate Injection, USP 1.2 mg/3 mL (0.4 mg/mL) syringe, packaged in ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
HYDROmorphone HCl Injection, USP 30 mg/30 mL (1 mg/mL) syringe, 5 x 30 mL Pre... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Morphine Sulfate Injection, USP, 2 mg/2 mL (1 mg/mL) syringe, packaged in 5 x... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL) syringe, packag... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Ketamine HCl Injection, USP 30 mg/3 mL (10 mg/mL*) syringes, packaged in 5 x ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) syringe, packaged in 5 x ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL) syringe, packaged i... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL) syringe, packaged in 5 x 4... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Morphine Sulfate Injection, USP, 1 mg/mL syringe, packaged in 5 x 1 mL Pre-Fi... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Amino Acid Injection 50 g/1000 mL (50 mg/mL) bags, Rx Only, Nephron 503B outs... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Phenylephrine HCl Injection, USP, 0.4 mg/10 mL (40 mcg/mL) syringe, packaged ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Fentanyl Citrate in 0.9% Sodium Chloride Injection, USP, 2500 mcg/250 mL (10 ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Neostigmine Methylsulfate Injection, USP, 4 mg/4 mL (1 mg/mL) syringe, packag... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
HYDROmorphone HCl Injection, USP, 6 mg/30 mL (0.2 mg/mL) syringes, 5 x 30 mL ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Glycopyrrolate Injection, USP, 0.6 mg/3 mL (0.2 mg/mL) syringes, packaged in ... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Ketamine HCl Injection, USP, 50 mg/5 mL (10 mg/mL*) syringes, packaged in 5 x... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
Morphine Sulfate Injection, USP, 30 mg/30 mL (1 mg/mL) syringe, packaged in 5... |
Lack of Assurance of Sterility |
Class II |
| Jun 30, 2022 |
8.4% Sodium Bicarbonate Injection, USP, 4.2 g/50 mL (84 mg/mL) 1 mEq/mL syrin... |
Lack of Assurance of Sterility |
Class II |